Search for content, post, videos

SynAct strengthens its patent portfolio

SynAct Pharma's recently acquired affiliate TXP Pharma was granted a patent in Canada related to “Alpha- and gamma-MSH analogues”. In addition, TXP’s patent application in another patent family relating to ”Exendin-4-analogues” has entered national phase in significant countries and reg
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.